$THRM

Gentherm Inc (THRM): Entry into a Material Definitive Agreement

Gentherm Inc (THRM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 d52623dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 Execution Version CUSIP Numbers : Deal: 37253NAJ4 Revolver: 37253NAK1 THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 29, 2026 among GENTHERM INCORPORATED , GENTHERM (TEXAS), INC. , GENTHERM MEDICAL, LLC , GENTH

Original reporting
Published Jul 2, 2026, 12:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 12:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$THRM
Neutral
medium confidence
Mentioned
$THRM
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$THRMNeutralLow
01

Why it matters

This is a liquidity/financing update that may affect Gentherm’s borrowing flexibility and risk profile; however, the excerpt does not include the key economic terms needed to gauge magnitude.

02

Market read

Financing-structure changes can move credit-sensitive equities, but without disclosed pricing/covenant details here, the trading signal is modest.

03

What to watch

Traders should verify in the full credit agreement: revolver size, maturity, interest-rate margin/fees, covenant thresholds, and any collateral/security changes—these determine whether the market should reprice credit risk.

Relevance 6/10Novelty 5/10Timing: 8-K filed July 2, 2026 (pre-market/early session disclosure)

Background

The 8-K reports Gentherm’s entry into a material definitive agreement and a direct financial obligation via a Third Amended and Restated Credit Agreement dated June 29, 2026.

Company-level read

Ticker impact

$THRMNeutralMedium confidence
Context

Gentherm entered a Third Amended and Restated Credit Agreement (revolver/letters of credit) dated June 29, 2026, filed via 8-K.

Expected impact

Likely limited immediate equity impact unless terms materially change leverage, pricing, or covenants; watch for spreads/covenant changes in the full exhibit.

Evidence & confidence

The filing confirms entry into a material definitive agreement and creation of direct financial obligations, but the provided excerpt is largely boilerplate and does not state key economic terms (size, pricing, maturity, covenants) that would drive a stronger price reaction.

Market effects

Credit-facility updates can signal funding conditions for auto-supply/thermal-management peers, but this filing alone is company-specific.

None indicated.

None indicated.

Counterpoint

If the amendment is primarily administrative (e.g., lender/agent changes) rather than economic, the equity impact may be negligible despite the “material definitive agreement” label.

Key entities

  • Gentherm Inc

    Subject of the 8-K; entered into the amended and restated credit agreement.

  • Bank of America, N.A.

    Administrative agent, swing line lender, and L/C issuer in the credit agreement.

  • JPMorgan Chase Bank, N.A.

    Co-syndication agent in the credit agreement.

Related articles

$THRMMed

Gentherm Incorporated Q2 2026 Earnings Call Summary

Gentherm reported Q2 2026 results and an earnings-call outlook. It cited 12.7% organic automotive growth versus a 3% global light-vehicle production decline, FDA 510(k) clearance for ThermAffyx, and an IME acquisition to access VA hospitals. Gentherm expects the Modine Performance Technologies merger to close in early Q4 2026, targeting $3.5B revenue by 2030, $400M buyback, and $800M committed financing.

$THRMHighAI 9/10

Gentherm (THRM) Q2 2026 Earnings Call Transcript

Gentherm (THRM) reported Q2 2026 product revenue of $416 million, up 11% year over year, with 9.5% organic growth. Automotive climate and comfort revenue rose 14.1% (12.7% ex FX). Adjusted EBITDA was $48.8 million and non-GAAP EPS $0.75. The company raised 2026 guidance to $1.6 billion revenue and $185-$200 million adjusted EBITDA, and authorized $400 million in buybacks.

$THRMMedAI 8/10

Gentherm Q2 Earnings Call Highlights

Gentherm (NASDAQ:THRM) reported adjusted EBITDA of $48.8M (11.7% of sales) and adjusted EPS of $0.75 for Q2. Management cited margin pressure from timing, inventory reductions and warranty accruals. Gentherm raised 2026 guidance to $1.6B revenue and $185M-$200M adjusted EBITDA, and expects ThermAffyx initial sales in Q3.

SK Hynix said to mull options for US$3 billion Chongqing plant

SK Hynix is considering options for its Chongqing, China semiconductor packaging and testing facility, including possibly bringing in an investor to accelerate growth. People familiar said a potential stake sale could value the plant at about US$3 billion and SK Hynix may keep a minority stake. Separately, it plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND.